Showing results (1811-1820 of 1,886) with videos related to

Sort By:
Pageof 189
Radiology|March 2, 2021
Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective StudyStephen W Duffy, László Tabár, Amy Ming-Fang Yen, et al.
Molecular Biology and Evolution|February 8, 2025
Selection Increases Mitonuclear DNA Discordance but Reconciles Incompatibility in African CattleXian Shi, Cheng Ma, Ningbo Chen, et al.
Journal of Thrombosis and Thrombolysis|November 19, 2011
Pharmacoinvasive therapy for ST elevation myocardial infarction in China: a pilot studyLing-hong Shen, Fang Wan, Long Shen, et al.
Scientific Reports|May 6, 2016
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis BHai Li, Liu-Ying Chen, Nan-Nan Zhang, et al.
Cancer Letters|November 8, 2017
The developmental transcription factor IRF6 attenuates ABCG2 gene expression and distinctively reverses stemness phenotype in nasopharyngeal carcinomaLiang Xu, Tie-Jun Huang, Hao Hu, et al.
Journal of the American College of Cardiology|October 15, 2025
Effects of Intensive Blood Pressure Control in Patients With Frailty: A Post Hoc Analysis From ESPRITShitian Li, Yue Peng, Yan Li, et al.
BMJ Open|November 11, 2020
Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic areaSi-Ting Lin, Dong-Fang Meng, Qi Yang, et al.
Digestive Diseases and Sciences|February 20, 2019
Endocut Versus Conventional Blended Electrosurgical Current for Endoscopic Biliary Sphincterotomy: A Meta-Analysis of ComplicationsDe-Feng Li, Mei-Feng Yang, Xin Chang, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Signal Transduction and Targeted Therapy|March 24, 2026
Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulationJiang Wang, Hanlin Wang, Runhua Du, et al.
Pageof 189